Discovery Laboratories Research Coverage Started at Stifel Nicolaus (DSCO)
Equities researchers at Stifel Nicolaus assumed coverage on shares of Discovery Laboratories (NASDAQ:DSCO) in a research report issued on Tuesday. The firm set a “buy” rating and a $5.00 price target on the stock. Stifel Nicolaus’ price target suggests a potential upside of 199.40% from the stock’s previous close.
Shares of Discovery Laboratories (NASDAQ:DSCO) opened at 1.67 on Tuesday. Discovery Laboratories has a 52 week low of $1.51 and a 52 week high of $3.05. The stock’s 50-day moving average is $1.70 and its 200-day moving average is $1.97. The company’s market cap is $142.3 million.
Discovery Laboratories (NASDAQ:DSCO) last issued its quarterly earnings data on Tuesday, August 5th. The company reported ($0.12) earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.15) by $0.03. The company had revenue of $1.09 million for the quarter. During the same quarter last year, the company posted ($0.18) earnings per share. On average, analysts predict that Discovery Laboratories will post $-0.54 earnings per share for the current fiscal year.
Discovery Laboratories, Inc is a biotechnology company focused on creating life-saving products for critical care patients with respiratory disease.
Receive News & Ratings for Discovery Laboratories Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Discovery Laboratories Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.